Astellas withdraws IRA lawsuit after avoiding CMS’ price negotiations list zbecker Wed, 09/06/2023 – 15:53 More: Astellas withdraws IRA lawsuit after avoiding CMS' price negotiations list Source: fierce
read moreBefore key Tagrisso showdown, J&J notches Rybrevant trial win in large lung cancer area aliu Wed, 09/06/2023 – 11:09 More: Before key Tagrisso showdown, J&J notches Rybrevant trial win in large lung cancer area Source: fierce
read moreAfter manufacturing setback at FDA, Ascendis strikes $150M royalty deal on its first commercial drug zbecker Wed, 09/06/2023 – 10:43 More: After manufacturing setback at FDA, Ascendis strikes 0M royalty deal on its first commercial drug Source: fierce
read moreAfter 1 year as standalone business, glassmaker Schott Pharma sets course for IPO kdunleavy Wed, 09/06/2023 – 10:20 More: After 1 year as standalone business, glassmaker Schott Pharma sets course for IPO Source: fierce
read moreAstraZeneca hit with FDA rejection for Ultomiris in rare autoimmune disorder fkansteiner Wed, 09/06/2023 – 10:10 More: AstraZeneca hit with FDA rejection for Ultomiris in rare autoimmune disorder Source: fierce
read moreTherapy is used among adult patients with symptomatic obstructive hypertrophic cardiomyopathy More: Bristol Myers Squibb’s Camzyos gets NICE recommendation Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals